PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Malaria drug combo could help prevent pregnancy complications in lupus patients

2014-01-23
(Press-News.org) Contact information: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Malaria drug combo could help prevent pregnancy complications in lupus patients An anti-malaria drug combination might be useful in helping to prevent pregnancy complications in women with lupus and the related disorder antiphospholipid syndrome, Yale School of Medicine researchers have found in a new study published in the American Journal of Reproductive Immunology.

Circulating antibodies called antiphospholipid antibodies are normally produced by the body to recognize and attack bacteria and other microbe. In those with lupus and/or antiphospholipid syndrome, however, these antibodies recognize and attack the body's own proteins, putting women at high risk for recurrent pregnancy loss and late gestational complications, such as preeclampsia.

Patients with lupus or antiphospholipid syndrome are often treated with the anti-malarial drug hydroxychloroquine. While the drug can be safely continued during pregnancy, it was unknown whether it might be beneficial in preventing pregnancy complications in women with lupus and/or antiphospholipid syndrome.

In this new study, senior author Vikki M. Abrahams, associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale, and first author and Yale medical student Caroline Albert explored whether the drug could treat obstetrical antiphospholipid syndrome.

Abrahams and Albert used a lab-based system to measure the detrimental effects of antiphospholipid antibodies on human placental trophoblast cell function.

"We found that hydroxychloroquine partially reversed some, but not all, of the detrimental effects of antiphospholipid antibodies on human placental cell function," said Abrahams. "So perhaps some form of combination therapy that includes hydroxychloroquine may be beneficial to pregnant patients with lupus and/or antiphospholipid syndrome."

INFORMATION:

Other authors on the study include William J. Schlesinger, Chez A. Viall, Melissa J. Mulla, Jan J. Brosens, and Lawrence W. Chamley.

The study was funded by grants from the Lupus Foundation of America and the March of Dimes. Caroline Albert was supported by the 2012 Lupus Foundation of America Gina M. Finzi Memorial Student Summer Fellowship.

Citation: American Journal of Reproductive Immunology (Jan. 2014)

END



ELSE PRESS RELEASES FROM THIS DATE:

Scripps Florida scientists offer new insight into neuron changes brought about by aging

2014-01-23
JUPITER, FL, January 22, 2013 – How aging affects communication between neurons is not well understood, a gap that makes it more difficult to treat a range of disorders, ...

Image or reality? Leaf research needs photos and lab analysis

2014-01-23
PROVIDENCE, R.I. [Brown University] — Every picture tells a story, but the story digital photos tell about how forests respond to climate change could be incomplete, according to new research. Scientists ...

Study finds paid search ads don't always pay off

2014-01-23
Watch Prof. Tadelis talk about his research: https://www.youtube.com/watch?v=rneZwbvvmcg&feature=youtu.be UNIVERSITY OF CALIFORNIA, BERKELEY'S HAAS SCHOOL OF BUSINESS - Businesses ...

World's dangerous neighborhoods produce aggressive children

2014-01-23
World's dangerous neighborhoods produce aggressive children DURHAM, N.C. -- Children around the world who grow up in dangerous neighborhoods exhibit more aggressive behavior, says a new Duke University-led study that is the first to examine the topic across a wide range ...

New drug shows promise in treating indolent non-Hodgkin lymphomas

2014-01-23
New drug shows promise in treating indolent non-Hodgkin lymphomas Idelalisib could be on the market later this year, pending FDA approval SEATTLE – Slow-growing, or indolent, non-Hodgkin lymphomas are difficult to treat, with most patients relapsing ...

Athletes' performance declines following contract years, MU researchers show

2014-01-23
COLUMBIA, Mo. – Professional athletes in the National Basketball Association and Major League Baseball can reap very large financial rewards, especially if their performance peaks during their "contract year," or the last season before an athlete signs a new contract or becomes a free agent.

Nighttime smartphone use zaps workers' energy

2014-01-23
Nighttime smartphone use zaps workers' energy EAST LANSING, Mich. — Using a smartphone to cram in more work at night results in less work the next day, indicates new research co-authored by a Michigan State University business scholar. In a pair of studies surveying ...

Study shows 1 in 5 women with ovarian cancer has inherited predisposition

2014-01-23
Study shows 1 in 5 women with ovarian cancer has inherited predisposition A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to ...

Study says sharks/rays globally overfished

2014-01-23
Study says sharks/rays globally overfished One quarter of the world's cartilaginous fish, namely sharks and rays, face extinction within the next few decades, according to the first study to systematically and globally assess their fate. The International ...

Increase in hemlock forest offsetting effect of invasive hemlock woolly adelgid for now

2014-01-23
Increase in hemlock forest offsetting effect of invasive hemlock woolly adelgid for now NEWTOWN SQUARE, Penn., Jan. 22, 2014 – Despite the accumulating destruction of a non-native invasive insect called the hemlock woolly adelgid, hemlock ...

LAST 30 PRESS RELEASES:

Low-glutamate diet linked to brain changes and migraine relief in veterans with Gulf War Illness

AMP 2025 press materials available

New genetic test targets elusive cause of rare movement disorder

A fast and high-precision satellite-ground synchronization technology in satellite beam hopping communication

What can polymers teach us about curing Alzheimer's disease?

Lead-free alternative discovered for essential electronics component

BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders

Skin cancer cluster found in 15 Pennsylvania counties with or near farmland

For platforms using gig workers, bonuses can be a double-edged sword

Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon

New study reveals key role of inflammasome in male-biased periodontitis

MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer

Donors enable record pool of TPDA Awards to Neuroscience 2025

Society for Neuroscience announces Gold Sponsors of Neuroscience 2025

The world’s oldest RNA extracted from woolly mammoth

Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show

Reading a quantum clock costs more energy than running it, study finds

Early MMR vaccine adoption during the 2025 Texas measles outbreak

Traces of bacteria inside brain tumors may affect tumor behavior

Hypertension affects the brain much earlier than expected

Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio

Drift logs destroying intertidal ecosystems

New test could speed detection of three serious regional fungal infections

New research on AI as a diagnostic tool to be featured at AMP 2025

New test could allow for more accurate Lyme disease diagnosis

New genetic tool reveals chromosome changes linked to pregnancy loss

New research in blood cancer diagnostics to be featured at AMP 2025

Analysis reveals that imaging is overused in diagnosing and managing the facial paralysis disorder Bell’s palsy

Research progress on leptin in metabolic dysfunction-associated fatty liver disease

Fondazione Telethon announces CHMP positive opinion for Waskyra™, a gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS)

[Press-News.org] Malaria drug combo could help prevent pregnancy complications in lupus patients